Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lesion Characteristics After Pulsed-Field Ablation in Patients With Atrial Fibrillation and a Left Common Ostium

NCT05812261 is registered in ClinicalTrials.gov with Onze Lieve Vrouwe Gasthuis as lead sponsor.

NCT NCT05812261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05812261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lesion Characteristics After Pulsed-Field Ablation in Patients With Atrial Fibrillation and a Left Common Ostium
Lead sponsor
Onze Lieve Vrouwe Gasthuis
Phase
Observational
Overall status
Completed
Start date
July 19, 2023
Completion date
February 29, 2024
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ablation therapy, atrial fibrillation, pulmonary vein isolation